Wall Street staged a rebound after the Treasury said it plans to boost buybacks of longer-dated bonds, a signal the US wants to lower borrowing costs after yields hit multi-decade highs. Lindsay Rosner, Head of Multi-Sector Investing at Goldman Sachs Asset Management, discusses her views on market resilience and global risk premiums.
A personalized vaccine developed by Moderna Inc. and Merck & Co. reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. Bloomberg's Sam Fazeli joins to discuss.
Harvard Management Co. disclosed a $2.2 billion stake in SpaceX, showing how the university's endowment has profited from an early bet on Elon Musk's giant rocket company. Janet Lorin, Bloomberg News Higher Education Reporter, discusses the disclosure and what it signals for other university investments.
US Treasury Secretary Scott Bessent made a fresh attempt to rein-in long-term borrowing costs from multi-year highs, sending Treasury yields and the dollar down. Ira Jersey, Chief US Interest Rates Strategist for Bloomberg Intelligence, discusses the move.
On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.
Scott Painter, chief executive officer of TrueCar, says automakers' incentives in "very soft new-car market'' are helping cushion consumers from the blow of tariffs like those being threatened by President Donald Trump against Canada. He speaks with Dani Burger on Bloomberg's "Open Interest.''
Joe Feldman, senior research analyst and assistant director of research at Telsey, says there is a "strong signal that the turnaround is working" at Target. The retailer lifted its full-year guidance after results outpaced estimates in the second-quarter.
Betterment CEO Sarah Levy sounds the alarm on Gen Z treating sports betting like investing. She joins Open Interest to explain why gambling apps, social-media financial advice and speculative trading are blurring the line between entertainment and long-term wealth building and why investors need stronger guardrails.
Target's turnaround may finally be working. Telsey Advisory Group Senior Managing Director and Assistant Director of Research Joseph Feldman joined Bloomberg Open Interest to break down why stronger traffic, sharper merchandising and a revamped food strategy are bringing shoppers back, even without tariff refunds. He also explains why Target shouldn't copy Walmart and which struggling retailers could lose the most market share.
Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence has more.
GET YOUR GRAFA EDGE NOW
Sign up free to unlock this feature
We'll switch on a 30-day Edge trial as a welcome gift
